BlackRock Japan’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$23.7M Buy
321,519
+2,324
+0.7% +$189K 0.08% 284
2016
Q3
$27.8M Buy
319,195
+6,474
+2% +$612K 0.1% 250
2016
Q2
$26.9M Buy
312,721
+1,437
+0.5% +$124K 0.1% 251
2016
Q1
$24.7M Buy
311,284
+8,992
+3% +$813K 0.09% 249
2015
Q4
$38M Sell
302,292
-1,763
-0.6% -$213K 0.14% 163
2015
Q3
$31.7M Buy
304,055
+209
+0.1% +$26.9K 0.13% 185
2015
Q2
$37.5M Buy
303,846
+13,301
+5% +$1.68M 0.14% 167
2015
Q1
$34.3M Sell
290,545
-11,680
-4% -$1.4M 0.14% 180
2014
Q4
$35.9M Buy
302,225
+26,776
+10% +$3.02M 0.14% 180
2014
Q3
$30.9M Buy
275,449
+17,835
+7% +$1.7M 0.13% 178
2014
Q2
$24.4M Sell
257,614
-22,212
-8% -$1.56M 0.11% 212
2014
Q1
$19.8M Buy
279,826
+13,792
+5% +$1.09M 0.09% 268
2013
Q4
$19.8M Sell
266,034
-38,726
-13% -$2.7M 0.09% 257
2013
Q3
$23.1M Buy
304,760
+47,255
+18% +$3.76M 0.11% 216
2013
Q2
$20.6M Buy
+257,505
New +$19M 0.09% 247

Other funds holding VRTX